Applied Therapeutics (APLT) Stock Going In For The Kill
Applied Therapeutics Inc. (NASDAQ: APLT) is a biotech company with a focus on galactosemia, diabetes, and cardiovascular conditions. Its lead candidate is AT-007 which will be at the front of galactosemia conditions in young children. With its market capitalization of $54 million, APLT is a small company, but one that holds immense potential, going forward. […]
Applied Therapeutics (APLT) Stock Going In For The Kill Read More »